These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1844916)
1. [Oncogene expression in malignant head and neck neoplasia]. Sartoris A; Aluffi P; Montemagno A; Gerbaudo EV; Gariglio M; Cavallo GP G Batteriol Virol Immunol; 1991; 84(1-12):25-30. PubMed ID: 1844916 [TBL] [Abstract][Full Text] [Related]
2. [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy]. Reyt E; Lavieille JP; Brambilla E; Barra Y; Riva C Ann Otolaryngol Chir Cervicofac; 1993; 110(6):310-5. PubMed ID: 8210089 [TBL] [Abstract][Full Text] [Related]
3. Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours. Spandidos DA; Lamothe A; Field JK Anticancer Res; 1985; 5(2):221-4. PubMed ID: 2581495 [TBL] [Abstract][Full Text] [Related]
4. ras mutations and expression in head and neck squamous cell carcinomas. Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162 [TBL] [Abstract][Full Text] [Related]
5. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Takes RP; Baatenburg de Jong RJ; Schuuring E; Litvinov SV; Hermans J; Van Krieken JH Anticancer Res; 1998; 18(6B):4793-800. PubMed ID: 9891559 [TBL] [Abstract][Full Text] [Related]
6. [Drug resistance, oncogenes, and anti-oncogenes in epithelial tumors]. Riva-Lavieille C Bull Cancer; 1994 Dec; 81 Suppl 2():105s-111s. PubMed ID: 7727855 [TBL] [Abstract][Full Text] [Related]
7. Multiple fractions of gamma rays do not induce overexpression of c-myc or c-Ki-ras oncogenes in human cervical carcinoma cells. Osmak M; Sorić J; Matulić M Neoplasma; 1993; 40(6):359-62. PubMed ID: 8289968 [TBL] [Abstract][Full Text] [Related]
8. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras. Volm M; Mattern J Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109 [TBL] [Abstract][Full Text] [Related]
9. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Berenson JR; Yang J; Mickel RA Oncogene; 1989 Sep; 4(9):1111-6. PubMed ID: 2476705 [TBL] [Abstract][Full Text] [Related]
10. [Amplification of the expression of the c-myc oncogene in bronchial epidermoid carcinoma in man]. Douc-Rasy S; Terrier P; Kemeny JL; Amouroux J; Riou G C R Acad Sci III; 1985; 301(13):621-6. PubMed ID: 3937573 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach. Onoda N; Maeda K; Chung YS; Yano Y; Matsui-Yuasa I; Otani S; Sowa M J Am Coll Surg; 1996 Jan; 182(1):55-9. PubMed ID: 8542090 [TBL] [Abstract][Full Text] [Related]
12. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck]. Jungehülsing M; Volling P HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916 [TBL] [Abstract][Full Text] [Related]
13. [Oncogenes in squamous epithelial cancers in the area of the head and neck]. Volling P; Jungehülsing M; Tesch H; Stennert E Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367 [TBL] [Abstract][Full Text] [Related]
14. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283 [TBL] [Abstract][Full Text] [Related]
15. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Somers KD; Cartwright SL; Schechter GL Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294 [TBL] [Abstract][Full Text] [Related]
16. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma. Field JK; Yiagnisis M; Spandidos DA; Gosney JR; Papadimitriou K; Vaughan ED; Stell PM Eur J Surg Oncol; 1992 Apr; 18(2):168-76. PubMed ID: 1582509 [TBL] [Abstract][Full Text] [Related]
17. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Field JK; Spandidos DA; Stell PM; Vaughan ED; Evan GI; Moore JP Oncogene; 1989 Dec; 4(12):1463-8. PubMed ID: 2687767 [TBL] [Abstract][Full Text] [Related]
18. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma. Xue H; Situ ZQ; Wang CJ; Wu JZ Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270 [TBL] [Abstract][Full Text] [Related]
19. Expression of cancer testis antigens in head and neck squamous cell carcinomas. Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205 [TBL] [Abstract][Full Text] [Related]
20. Potential biomarkers for head and neck squamous cell carcinoma. Brown JJ; Xu H; Nishitani J; Mohammed H; Osborne R; Teklehaimanot S; Gill G; Liu X Laryngoscope; 2003 Mar; 113(3):393-400. PubMed ID: 12616185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]